NCT06489821View on ClinicalTrials.gov

STereotactic Body Radiotherapy (SBRT) for Oligoprogressive Breast Cancer

NANot yet recruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Metastatic Breast CancerOligoprogression
Interventions
RADIATION

Stereotactic body radiotherapy

Stereotactic body radiotherapy in 5 fractions (body) or 2 or 4 fractions (spine) plus continuation of first line systemic therapy

All Listed Sponsors
collaborator

Juravinski Cancer Centre Foundation

OTHER

lead

Juravinski Cancer Center

OTHER